| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8838771 | Brain Research Bulletin | 2018 | 40 Pages |
Abstract
RGMa may be involved in I/R injury associated with BBB dysfunction via the CDC-42/PAK-1 signal pathway and may be a promising therapeutic target for I/R injury.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Min Li, Yuetao Wen, Rongrong Zhang, Fei Xie, Gang Zhang, Xinyue Qin,